By NewsDesk  @infectiousdiseasenews Clinical-stage biotechnology company, Vivaldi Biosciences, announced positive preclinical data supporting further development of Delta-19, its combination vaccine...

By NewsDesk  @infectiousdiseasenews The Zimbabwe Ministry of Health and Child Care, with support from the World Health Organization (WHO), Gavi, the vaccine alliance and the United Nations Children’s...

By NewsDesk  @infectiousdiseasenews Specialty vaccine company, Valneva announced recently it has been awarded Breakthrough Therapy Designation for its single-shot chikungunya vaccine candidate, VLA1553,...

Biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, Moderna, announced Wednesday  the first participants have been dosed in the Phase 1/2 study of mRNA-1010, the Company’s...

By NewsDesk  @infectiousdiseasenews People who receive mRNA COVID-19 vaccines are up to 91 percent less likely to develop the disease than those who are unvaccinated, according to a new nationwide study...

By NewsDesk  @infectiousdiseasenews The International AIDS Vaccine Initiative (IAVI) was awarded €22.8 million by the European & Developing Countries Clinical Trials Partnership and the Coalition...

By NewsDesk  @infectiousdiseasenews In two separate articles in the Annals of Neurology, clinicians in India and England report cases of a rare neurological disorder called Guillain-Barre syndrome...

By Press Release  @infectiousdiseasenews Wading into the contentious issues of vaccine mandates and vaccine credentials, the American Medical Association (AMA) adopted policy that calls for strong protections...

The American Medical Association (AMA) today released a new survey among practicing physicians that shows more than 96 percent of surveyed U.S. physicians have been fully vaccinated for COVID-19, with...

By NewsDesk  @infectiousdiseasenews Bavarian Nordic A/S  announced Friday that the Company was recently engaged by Public Health England (PHE) and the Medicines and Health Products Regulatory Agency...